NASDAQ · LEVIX
Lazard US Equity Concentrated Portfolio
$14.59+$0.28 (+1.97%)
Lazard US Equity Concentrated Portfolio’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
NASDAQ · GGOAX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Goldman Sachs Mid Cap Growth Fund Class A Shares’s quoted price sits in the lower half of its reported 52-week range, 18.23% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Goldman Sachs Mid Cap Growth Fund Class A Shares’s forward annual dividend is $2.80 per share, paid annual. The forward yield is 25.28% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund's central objective is to achieve substantial capital growth over an extended period. Under typical market conditions, it dedicates a minimum of 90% of its total assets, as valued at the time of acquisition, to equity holdings, primarily targeting companies with medium market capitalizations. While predominantly invested in publicly traded U.S. securities, the fund maintains the option to allocate up to 25% of its overall capital to international stocks. This may include securities issued by companies in emerging economies and those whose prices are quoted in foreign denominations.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:04 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$14.59+$0.28 (+1.97%)
Lazard US Equity Concentrated Portfolio’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$8.24+$0.08 (+0.98%)
Royce Small-Cap Total Return Fund;Service’s quoted price sits in the upper half of its reported 52-week range, 3.85% below the high.
$23.75+$0.13 (+0.55%)
William Blair International Leaders Fund Class N Shares’s quoted price sits in the upper half of its reported 52-week range, 8.65% below the high.
$24.00+$0.13 (+0.54%)
William Blair International Leaders Fund R6 Class Shares’s quoted price sits in the upper half of its reported 52-week range, 8.57% below the high.
$13.66+$0.10 (+0.74%)
Virtus Ceredex Mid-Cap Value Equity I’s quoted price sits in the upper half of its reported 52-week range, 8.75% below the high.
$17.90+$0.46 (+2.64%)
Baird Mid Cap Growth Fund - Investor Class’s quoted price sits in the upper half of its reported 52-week range, 9.5% below the high.
$20.19+$0.51 (+2.59%)
Baird Mid Cap Growth Fund - Institutional Class’s quoted price sits in the upper half of its reported 52-week range, 8.06% below the high.
$64.83-$0.76 (-1.16%)
Voya Large-Cap Growth Fund;I’s quoted price sits in the upper half of its reported 52-week range, 9.76% below the high.
